Launch week offerEnds in00h00m00s

annual Promonthly Pro

Theresa Scholl

Has grant

Sigmund Freud PrivatUniversität Wien

Austria

Research Interests

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Explore related searches

Professors in Austria

Recent Grants

Grant: Close

Tuberöse Skleröse Forschungspreis 2015

Open Date:

Close Date:

Grant: Close

Herbert Reisner Preis für Epileptologie 2024 - corresponding author

Open Date:

Close Date:

Grant: Close

Herbert Reisner Preis für Epileptologie 2022 - corresponding author

Open Date:

Close Date:

Grant: Close

EGFR/SEGA Study 2021-2024

Open Date:

Close Date:

Articles (5)

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2023

Collaborators (9)

Alberto De Luca

Assistant Professor

University Medical Center Groningen

NETHERLANDS

View details

David Kwiatkowski

Professor

Harvard Medical School

UNITED STATES

View details

Catherine Riney

University of Queensland

AUSTRALIA

View details

Sylvain Rheims

Professor of Neurology

Université Claude Bernard Lyon 1

FRANCE

View details

Eleonora Aronica

Neuropathologist

University of Amsterdam

NETHERLANDS

View details

Angela M. Kaindl

GERMANY

View details

Wim Otte

Associate Professor Clinical Epidemiology

Universitair Medisch Centrum Utrecht

NETHERLANDS

View details

Miroslav Maminak

Head of ICU

University Hospital in Motol

CZECH REPUBLIC

View details

Steffen Syrbe

Director ad Interim Clinic 5, Full Professor, Consultant Neuropediatrics and Pediatrics, Head of Division for Pediatric Epileptology

Heidelberg University

GERMANY

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Theresa Scholl

Research Interests

Make your next move.

Explore related searches

Recent Grants

Articles (5)

Long-term neuropsychologic outcome of pre-emptive mTOR inhibitor treatment in children with tuberous sclerosis complex (TSC) under 4 months of age (PROTECT), a two-arm, randomized, observer-blind, controlled phase IIb national multicentre clinical trial: study protocol

Vigabatrin‐associated brain magnetic resonance imaging abnormalities and clinical symptoms in infants with tuberous sclerosis complex

Outcome of Epilepsy Surgery in MRI-Negative Patients Without Histopathologic Abnormalities in the Resected Tissue

Targeting the EGFR pathway: An alternative strategy for the treatment of tuberous sclerosis complex?

Molecular EPISTOP, a comprehensive multi-omic analysis of blood from Tuberous Sclerosis Complex infants age birth to two years

Collaborators (9)

Alberto De Luca

David Kwiatkowski

Catherine Riney

Sylvain Rheims

Eleonora Aronica

Angela M. Kaindl

Wim Otte

Miroslav Maminak

Steffen Syrbe

Make your next move.